Novoheart is at the forefront of some of the rapid advances being made using stem cell research. It engineers new heart cells and tissues using a mix of stem cells harvested from the body and artificial materials such as collagen. Kevin Costa, Novoheart's co-founder and chief scientific officer, talked to Globalive Chairman Anthony Lacavera about the new technology. (Source: Bloomberg)